Neutropenia with fever (febrile neutropenia [FN]) is a serious consequence of myelosuppressive chemotherapy that can result in hospitalization and the need for IV antibiotics. FN can also result in dose reductions, delays, or even discontinuation of chemotherapy, which, in turn, may compromise patient outcomes. It is thus important to identify the risk for developing FN so that patients can receive optimal chemotherapy while their risk for FN is appropriately managed.
  • type Extension
  • status Active
  • version

5 11/02/2017 18:25:37 Peter Lamb Fhir
4 11/02/2017 18:25:30 Peter Lamb Fhir
3 11/02/2017 18:22:55 Peter Lamb Fhir
2 11/02/2017 18:22:47 Peter Lamb Fhir
1 11/02/2017 18:18:09 Peter Lamb Fhir

Last updated on